9NTO image
Entry Detail
PDB ID:
9NTO
Title:
Structure of Cap9-CdnD complex containing NDG modification
Biological Source:
Source Organism:
PDB Version:
Deposition Date:
2025-03-18
Release Date:
2025-05-07
Method Details:
Experimental Method:
Resolution:
2.15 Å
R-Value Free:
0.23
R-Value Work:
0.20
R-Value Observed:
0.20
Space Group:
P 21 21 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:CdnD
Chain IDs:A
Chain Length:320
Number of Molecules:1
Biological Source:Hyphomicrobiales
Polymer Type:polypeptide(L)
Description:Cap9
Chain IDs:B
Chain Length:191
Number of Molecules:1
Biological Source:Hyphomicrobiales
Primary Citation
Deazaguanylation is a nucleobase-protein conjugation required for type IV CBASS immunity.
Biorxiv ? ? ? (2025)
PMID: 40236162 DOI: 10.1101/2025.04.06.647259

Abstact

7-deazapurines are nucleobase analogs essential for nucleic acid modifications in nearly all cellular life. Here, we discover a role for 7-deazapurines in protein modification within type IV CBASS anti-phage defense and define functions for CBASS ancillary proteins Cap9 and Cap10 in nucleobase-protein conjugation. A structure of Cap10 reveals a tRNA transglycosylase-family enzyme remodeled to bind the modified N-terminus of a partner cGAS/DncV-like nucleotidyltransferase linked to a 7-amido-7-deazaguanine (NDG) nucleobase. The structure of Cap9 explains how this QueC-like enzyme co-opts a 7-deazapurine biosynthetic reaction mechanism for NDG conjugation. We demonstrate that Cap9, Cap10, and NDG conjugation are essential for host defense against phage infection. Our results define a previously unknown 7-deazapurine protein modification and explain how nucleobase biosynthetic machinery has been repurposed for antiviral immunity.

Legend

Protein

Chemical

Disease

Primary Citation of related structures